Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
229.19
-1.04 (-0.45%)
At close: Mar 24, 2025, 4:00 PM
238.00
+8.81 (3.84%)
After-hours: Mar 24, 2025, 7:17 PM EST
BDX Market Cap
BDX has a market cap or net worth of $65.81 billion as of March 25, 2025. Its market cap has decreased by -4.14% in one year.
Market Cap
65.81B
Enterprise Value
83.84B
1-Year Change
-4.14%
Ranking
Category
Stock Price
$229.19
Market Cap Chart
Since December 1, 1998, BDX's market cap has increased from $10.89B to $65.81B, an increase of 504.14%. That is a compound annual growth rate of 7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2025 | 65.81B | 0.33% |
| Dec 31, 2024 | 65.59B | -7.37% |
| Dec 29, 2023 | 70.81B | -1.74% |
| Dec 30, 2022 | 72.06B | 0.89% |
| Dec 31, 2021 | 71.43B | -1.58% |
| Dec 31, 2020 | 72.57B | -1.34% |
| Dec 31, 2019 | 73.56B | 21.69% |
| Dec 31, 2018 | 60.44B | 23.86% |
| Dec 29, 2017 | 48.80B | 38.84% |
| Dec 30, 2016 | 35.15B | 8.24% |
| Dec 31, 2015 | 32.47B | 21.55% |
| Dec 31, 2014 | 26.72B | 24.57% |
| Dec 31, 2013 | 21.45B | 39.26% |
| Dec 31, 2012 | 15.40B | -4.09% |
| Dec 30, 2011 | 16.06B | -17.39% |
| Dec 31, 2010 | 19.44B | 3.94% |
| Dec 31, 2009 | 18.70B | 12.46% |
| Dec 31, 2008 | 16.63B | -18.44% |
| Dec 31, 2007 | 20.39B | 17.82% |
| Dec 29, 2006 | 17.30B | 14.26% |
| Dec 30, 2005 | 15.14B | 5.26% |
| Dec 31, 2004 | 14.39B | 37.33% |
| Dec 31, 2003 | 10.48B | 32.87% |
| Dec 31, 2002 | 7.88B | -8.07% |
| Dec 31, 2001 | 8.58B | -2.81% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 776.31B |
| UnitedHealth Group | 472.45B |
| Johnson & Johnson | 393.50B |
| AbbVie | 369.26B |
| Novo Nordisk | 335.17B |
| Merck & Co. | 233.18B |
| AstraZeneca | 229.25B |
| Abbott Laboratories | 220.62B |